Galmed Pharmaceuticals: Strong Fundamentals Powering A NASH Innovator (NASDAQ:GLMD) | Seeking Alpha
IJERPH | Free Full-Text | Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives | HTML
ARAMCHOL RESULTS QUICK ANALYSIS | NASH BIOTECHS | www.nashbiotechs.com
Key targets for drugs in phase 2 and phase 3 clinical trials. | Download Scientific Diagram
Multicenter Trial png images | PNGWing
Galmed closes patient enrolment for Phase IIb ARREST study of Aramchol to treat liver diseases - Clinical Trials Arena
Drug discovery and treatment paradigms in nonalcoholic steatohepatitis - Noureddin - 2020 - Endocrinology, Diabetes & Metabolism - Wiley Online Library
Diabetes & Metabolism Journal
Aramchol - Wikipedia
Galmed And Aramchol In NASH: Moving On Higher (NASDAQ:GLMD) | Seeking Alpha
One-year results of the Global Phase 2b randomized placebo-controlled ARREST Trial of Aramchol, a Stearoyl CoA Desaturasemodulator in NASH patients
An Update on Efficacy and Safety of Emerging Hepatic Antifibrotic Agents
Frontiers | Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments | Pharmacology
Aramchol attenuated lipid accumulation and ROS production in... | Download Scientific Diagram
Development of new drugs for the treatment of nonalcoholic steatohepatitis - Tang - 2020 - Journal of Digestive Diseases - Wiley Online Library
PBC NASH on Twitter: "ARREST: Phase IIb trial of aramchol in noncirrhotic patients with NASH is under way. #PBCNASH http://t.co/nESuRWVrrF" / Twitter
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
New Data on Aramchol TM for the Treatment of Non-alcoholic Steatohepatitis: Exploring Potential for Greater Efficacy and the Effect on Glucose Metabolism - European Medical Journal
A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR) | Clinical Research Trial Listing ( Nonalcoholic Steatohepatitis (NASH) ) ( NCT04104321 )
EX-99.1 2 tm216865d1_ex99-1.htm EXHIBIT 99.1 Exhibit
